The weekly litigation news digest is live. Subscribe now

IP Verse

Crystalline Forms Of An Androgen Receptor Modulator - EP2858985

The patent EP2858985 was granted to Aragon Pharmaceuticals on Apr 18, 2018. The application was filed on Jun 4, 2013 under application number EP13800681A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2858985

ARAGON PHARMACEUTICALS
Application Number
EP13800681A
Filing Date
Jun 4, 2013
Status
Opposition Rejected
Aug 2, 2024
Publication Date
Apr 18, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Anti-androgen drug that suppresses both AR nuclear translocation and AR binding to androgen response elements in DNA. The drug inhibits both AR nuclear translocation and AR binding to androgen response elements in DNA.

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GENERICS UKJan 18, 2019TER MEER STEINMEISTER & PARTNERADMISSIBLE
LUIGIJan 18, 2019TER MEER STEINMEISTER & PARTNERADMISSIBLE
SAGITTARIUSJan 18, 2019SAGITTARIUSADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20100450423
DESCRIPTIONUS5323907
DESCRIPTIONWO2007126765
DESCRIPTIONWO2008119015
INTERNATIONAL-SEARCH-REPORTUS2007004753
INTERNATIONAL-SEARCH-REPORTWO2007127010
OPPOSITIONWO2007126765
OPPOSITIONWO2008119015
OPPOSITIONWO2013184681
SEARCHWO2007126765
SEARCHWO2008119015
SEARCHWO2011103202

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents